drugset / Trial / NCT00314132

Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.

NCT00314132

Phase 3 Completed 2004 enrolled Sanofi
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to assess whether ChimeriVax™ JE vaccine (a new vaccine to be used for vaccination against Japanese encephalitis) is safe and well tolerated when compared to placebo (dummy) vaccination.

Timeline

Start
2005-10
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ChimeriVax™-JE Vaccine 0.5 ml Subcutaneous

Indications